235 related articles for article (PubMed ID: 36748574)
1. Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab.
Loveikyte R; Bourgonje AR; van der Reijden JJ; Bulthuis MLC; Hawinkels LJAC; Visschedijk MC; Festen EAM; van Dullemen HM; Weersma RK; van Goor H; van der Meulen-de Jong AE; Dijkstra G
Inflamm Bowel Dis; 2023 Aug; 29(8):1272-1284. PubMed ID: 36748574
[TBL] [Abstract][Full Text] [Related]
2. Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocol.
Loveikyte R; Duijvestein M; Mujagic Z; Goetgebuer RL; Dijkstra G; van der Meulen-de Jong AE
BMJ Open; 2024 Jan; 14(1):e077511. PubMed ID: 38296290
[TBL] [Abstract][Full Text] [Related]
3. Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease.
Aksan A; Wohlrath M; Iqbal TH; Dignass A; Stein J
J Crohns Colitis; 2020 Mar; 14(3):316-322. PubMed ID: 31665264
[TBL] [Abstract][Full Text] [Related]
4. Real-world experience of intravenous iron sucrose supplementation and dynamics of soluble transferrin receptor and hepcidin in a Spanish cohort of absolute iron deficient patients.
Tarancon-Diez L; Iriarte-Gahete M; Sanchez-Mingo P; Perez-Cabeza G; Romero-Candau F; Pacheco YM; Leal M; Muñoz-Fernández MÁ
Biomed Pharmacother; 2023 Nov; 167():115510. PubMed ID: 37757490
[TBL] [Abstract][Full Text] [Related]
5. Threshold Ferritin Concentrations Reflecting Early Iron Deficiency Based on Hepcidin and Soluble Transferrin Receptor Serum Levels in Patients with Absolute Iron Deficiency.
Tarancon-Diez L; Genebat M; Roman-Enry M; Vázquez-Alejo E; Espinar-Buitrago MS; Leal M; Muñoz-Fernandez MÁ
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432426
[TBL] [Abstract][Full Text] [Related]
6. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
[TBL] [Abstract][Full Text] [Related]
7. BODY IRON STATUS INDICATORS AND INFLAMMATION INDICATORS DURING INFLAMMATORY BOWEL DISEASE THERAPY IN CHILDREN AND ADOLESCENTES.
Corrêa FF; Sdepanian VL
Arq Gastroenterol; 2021; 58(1):48-54. PubMed ID: 33909796
[TBL] [Abstract][Full Text] [Related]
8. Iron Status and Homeostasis Across 2 Competitive Seasons in NCAA Division I Collegiate Cross-Country Runners Residing at Low Altitude.
Goodrich JA; Frisco DJ; Kim S; VanBaak K; Holliday M; Rueda M; Poddar S; Byrnes WC
Int J Sports Physiol Perform; 2022 Dec; 17(12):1716-1724. PubMed ID: 36343619
[TBL] [Abstract][Full Text] [Related]
9. Serum hepcidin in inflammatory bowel diseases: biological and clinical significance.
Bergamaschi G; Di Sabatino A; Albertini R; Costanzo F; Guerci M; Masotti M; Pasini A; Massari A; Campostrini N; Corbella M; Girelli D; Corazza GR
Inflamm Bowel Dis; 2013 Sep; 19(10):2166-72. PubMed ID: 23867871
[TBL] [Abstract][Full Text] [Related]
10. Serum Hepcidin and Iron Absorption in Paediatric Inflammatory Bowel Disease.
Martinelli M; Strisciuglio C; Alessandrella A; Rossi F; Auricchio R; Campostrini N; Girelli D; Nobili B; Staiano A; Perrotta S; Miele E
J Crohns Colitis; 2016 May; 10(5):566-74. PubMed ID: 26733407
[TBL] [Abstract][Full Text] [Related]
11. Serum Hepcidin in Children with Inflammatory Bowel Disease.
Krawiec P; Mroczkowska-Juchkiewicz A; Pac-Kożuchowska E
Inflamm Bowel Dis; 2017 Dec; 23(12):2165-2171. PubMed ID: 28945637
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Observational Study Analyzing the Diagnostic Value of Hepcidin-25 for Anemia in Patients with Inflammatory Bowel Diseases.
Petrović S; Tarabar D; Ćujić D; Stamenkovic D; Petrović M; Rančić N; Subota V; Perišić N; Bezmarević M
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612376
[TBL] [Abstract][Full Text] [Related]
13. Soluble transferrin receptor and soluble transferrin receptor/log ferritin index in diagnosis of iron deficiency anemia in pediatric inflammatory bowel disease.
Krawiec P; Pac-Kożuchowska E
Dig Liver Dis; 2019 Mar; 51(3):352-357. PubMed ID: 30538074
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis.
Arnold J; Sangwaiya A; Bhatkal B; Geoghegan F; Busbridge M
Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):425-9. PubMed ID: 19262400
[TBL] [Abstract][Full Text] [Related]
15. Iron status in patients with chronic heart failure.
Jankowska EA; Malyszko J; Ardehali H; Koc-Zorawska E; Banasiak W; von Haehling S; Macdougall IC; Weiss G; McMurray JJ; Anker SD; Gheorghiade M; Ponikowski P
Eur Heart J; 2013 Mar; 34(11):827-34. PubMed ID: 23178646
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin-25 vs. conventional clinical biomarkers in the diagnosis of functional iron deficiency.
Enko D; Wagner H; Kriegshäuser G; Kimbacher C; Stolba R; Worf E; Halwachs-Baumann G
Eur J Haematol; 2015 Dec; 95(6):507-13. PubMed ID: 25598480
[TBL] [Abstract][Full Text] [Related]
17. Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease.
Daude S; Remen T; Chateau T; Danese S; Gastin I; Baumann C; Gueant JL; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2020 Jun; 51(11):1087-1095. PubMed ID: 32323356
[TBL] [Abstract][Full Text] [Related]
18. Effects of iron supplementation on serum hepcidin and serum erythropoietin in low-birth-weight infants.
Berglund S; Lönnerdal B; Westrup B; Domellöf M
Am J Clin Nutr; 2011 Dec; 94(6):1553-61. PubMed ID: 22071701
[TBL] [Abstract][Full Text] [Related]
19. Lactoferrin for iron-deficiency anemia in children with inflammatory bowel disease: a clinical trial.
El Amrousy D; El-Afify D; Elsawy A; Elsheikh M; Donia A; Nassar M
Pediatr Res; 2022 Sep; 92(3):762-766. PubMed ID: 35681097
[TBL] [Abstract][Full Text] [Related]
20. Imbalance of Iron Availability and Demand in Patients With Acute and Chronic Heart Failure.
Lanser L; Poelzl G; Messner M; Ungericht M; Zaruba MM; Hirsch J; Hechenberger S; Obersteiner S; Koller B; Ulmer H; Weiss G
J Am Heart Assoc; 2024 May; 13(9):e032540. PubMed ID: 38639356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
